Adaptive optics technology reveals eye’s cellular structure with unprecedented detail Researchers today reported that the tiny light-sensing cells referred to as rods have already been clearly and directly imaged in the living eyesight for the very first time. Using adaptive optics , the same technology astronomers make use of to study distant galaxies and stars, scientists can easily see through the murky distortion of the outer eyes, revealing the eye’s cellular structure with unprecedented details. This innovation, described in two papers in the Optical Society’s open gain access to journal Biomedical Optics Express, will help doctors diagnose degenerative eyes disorders sooner, resulting in quicker intervention and more effective treatments fda approved .
This additional financing will help fund the progress of our trials in cervical cancer in India and in CIN 2/3 in the US, among our other studies. We have started releasing data and intend to continue to share news regarding those trials throughout the first quarter of 2012, commented Advaxis Chairman/CEO Thomas A. Moore. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., , acted as the distinctive placement agent for the purchase.. Additional financing to fund Advaxis’ cervical cancer trials Advaxis, Inc., , a innovator in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement with specific accredited investors, for the purchase of the aggregate principal worth of around $1.2 million of Convertible Promissory Notes for an aggregate purchase price of around $1.0 million.